Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.

Nanomedicine (Lond)

Department of Medical Microbiology & Immunology, Faculty of Medicine, Assiut University, Assiut, 71526, Egypt.

Published: September 2020

The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific treatment against SARS-CoV-2, effective vaccines and antiviral agents are urgently needed to properly restrain the COVID-19 pandemic. Repositioned drugs such as remdesivir have revealed a promising clinical efficacy against COVID-19. Interestingly, nanomedicine as a promising therapeutic approach could effectively help win the battle between coronaviruses (CoVs) and host cells. This review discusses the potential therapeutic approaches, in addition to the contribution of nanomedicine against CoVs in the fields of vaccination, diagnosis and therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388682PMC
http://dx.doi.org/10.2217/nnm-2020-0247DOI Listing

Publication Analysis

Top Keywords

nanomedicine promising
8
promising approach
4
approach for diagnosis
4
for diagnosis treatment
4
treatment prophylaxis
4
prophylaxis covid-19
4
covid-19 covid-19 pandemic
4
covid-19 pandemic caused
4
caused newly
4
newly emerged
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!